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formation of carcinogen-lipid adduct and its correlation
Lipids are good sources of energy in the body and are with DNA or protein adducts. The lipids from serum or composed of cellular membrane and tissue. There is some hepatocyte membranes of Sprague-Dawley rats, human evidence that lipids could be involved in carcinogenesis. About serum and standard major lipids were in vitro reacted 50% of all cancer patients show a syndrome of cachexia,
with benzo[a]pyrene (B[a]P) and B[a]P metabolites. 7,8-
characterized by the loss of adipose tissue and skeletal muscle Dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene mass (reviewed in ref. 7) . Lipids are easily peroxidized to (BPDE-I), an ultimate carcinogenic form of B[a]P, was lipid peroxides by free radicals (8) , and malondialdehyde is covalently bound to triglyceride (TG). BPDE-I-TG adducts used to estimate lipid damage during lipid peroxidation. Lipid isolated by thin-layer chromatography (TLC) were further peroxidation products are also bound to DNA in the human detected by high-performance liquid chromatography. TGs, liver and leukocytes (9, 10) . In recent studies, changes in the including triolein, tripalmitin and tristearin, showed fatty acid composition of plasma lipids were characterized in positive reactions with BPDE-I. However, cholesterol, patients with malignancy by nuclear magnetic resonance and phospholipids (phosphatidylcholine, phosphatidyl-ethanolgas-liquid chromatography (11, 12) , and lipid analysis was also amine, phosphatidyl-inositol and sphingomyelin) and nonperformed in smooth muscle tumors (13) . In breast cancer esterified fatty acids (palmitic acid, oleic acid, linoleic acid patients, serum triglyceride (TG), total cholesterol, high-density and stearic acid) did not react with BPDE-I. In addition, lipoprotein, low-density lipoprotein and very-low density lipoother B[a]P metabolites (B[a]P-phenols and -diols) did not protein levels were quantified in order to evaluate the changes react with TG. TG appeared to be the most reactive lipid yet in serum lipids and lipoproteins in the early and advanced studied with respect to its ability to form an adduct with stages of the disease. These studies were undertaken to assess BPDE-I. There was a clear-cut dose-related formation of the lipid changes due to the presence of malignancy and to [1, 3- Materials and methods such damage has been used as a biomarker (1) . Biomarkers are defined as cellular, biochemical or molecular alterations in 
Preparation of total lipid from animals and humans
The total lipid was prepared from hepatocytes or sera of Sprague-Dawley rats, and human sera. After a male rat (250 Ϯ 20 g) was anesthetized, the abdomen was cut open and perfusion was initiated through the portal vein. Ca 2ϩ -free buffer and collagenase buffer were successively pumped from a reservoir through the portal vein at 37°C (17) . The released hepatocytes were cultured in a CO 2 incubator for 24 h and sound hepatocytes were separated. Whole blood (10 ml) was taken from the animals or human volunteers (mean age: 24 Ϯ 2, n ϭ 10) and the serum was separated promptly after centrifugation at 3000 r.p.m. for 20 min. Folch solution [chloroform:methanol, 2:1 (v/v)] was added to hepatocytes or serum and agitated for 3 h. After centrifugation at 3000 r.p.m. for 10 min, the lower layer was separated and the concentration of total lipid was determined by UV absorption spectroscopy at 590 nm as described in the dichromate oxidation method (18) . The total lipid was dissolved in tetrahydrofuran (THF) at a concentration of 1 mg/ml. The male rats (250 Ϯ 20 g) were orally treated with B[a]P (25 mg/rat) in 2 ml of corn oil to investigate B[a]P-lipid adducts in vivo. After 6 h, the rats were anesthetized and 10 ml of whole blood was taken from the abdominal aorta.
Other procedures were as above. P metabolites (50 µl, 1 mg/ml THF or chloroform) for 2 h at 37°C. After incubation, each sample was applied as a 1 cm streak to thinlayer chromatography (TLC) plates (silica gel 60; Merck, Darmstadt, Germany) and the solvent front was allowed to migrate to a predetermined boundary mark. The cholesterol and TG were separated using a THF/hexane two component system: THF/hexane/formic acid (20:80:2 by vol.) to 18 cm above the origin and THF/hexane/formic acid (100:20:2 by vol.) to 10 cm (19, 20) . Total lipids, phospholipids and free fatty acids were separated using a threedevelopment system: diethylether/hexane/ammonia (50:50:0.25 by vol.) to 18 cm above the origin, chloroform/methanol/water/ammonia (70:30:3:2 by vol.) to 10 cm and ethylacetate/acetone/water/glacial acetic acid (40:40:2:1 by vol.) to 16 cm (21). After TLC the plates were dried in a desiccator, and the spots were located under UV light (254 and 365 nm) or observed after spraying with 10% sulfuric acid. The R f values from the reaction of TG, tripalmitin, triolein and tristearin with BPDE-I were all 0.88.
In vitro detection of lipid adducts

Analysis of lipid adducts and modification levels by HPLC
Each standard lipid (50 µg) was mixed with [1,3-3 H]BPDE-I (3.5 nmol) in THF for 2 h at 37°C and was applied to a TLC plate. Solvent systems were as described above. All spots were scraped off into a screw-cap scintillation vial and the radioactivity was measured using a liquid scintillation counter (LSC, Pharmacia-LKB 1209 Rackbeta, Uppsala, Sweden). The modification level of the [1,3-3 H]BPDE-I-TG adduct was determined on the basis of the molar ratio of [1, H]BPDE-I to TG. For HPLC analysis, the reaction mixture was centrifuged and the supernatant was filtered through a 0.45 µm membrane (Table I) .
Discussion
Biomolecular damage is widely believed to be a critical event during mutagenesis and carcinogenesis. Carcinogenmacromolecule adducts (DNA, RNA or protein adducts) have been largely studied with known chemical carcinogens (24). However, the analysis of DNA or protein adducts in human tissues still has limitations in terms of sampling, sensitivity and specificity. DNA or protein adducts have been measured in human tissues for the etiological investigation of carcinogen exposure and qualitative risk assessment. Lipids are abundant could be useful as an alternative to DNA or protein adducts. In this study, BPDE-lipid adduct formation was detected in vitro and in vivo by the exposure of BPDE-I or B[a]P. The formation of the BPDE-lipid adduct in vitro indicated that the TGs, including tripalmitin, triolein and tristearin, are likely target lipids for BPDE-I. TGs (also called fats, triglycerols and depot lipids) constitute 90% of dietary lipids and are the major form of metabolic energy storage in humans (40-150 mg/100 ml blood in adults). These non-polar, waterinsoluble substances consist of glycerol triesters of fatty acids such as palmitic, oleic and stearic acids (25).
In the TGs of human lipids, palmitate tends to be concentrated at position 1 and oleate at position 2 of the base glycerol structure (26) . Considering the structure of the TG species, a possible explanation for the formation of the BPDE-I-TG adduct might be the covalent binding of position 10 of BPDE-I to the ester bonds of TG between the glycerol portion and free fatty acids of TG, though this must be investigated further. One important role of TG is transporting free fatty acids, either to various tissues or during the biosynthesis of several lipids in the body (27,28). Therefore, the adduct TG adduct formation are obvious such that the lipid damage or TG adducts could serve as a surrogate biomarker for DNA solvent system), spot C was BPDE-I-TG adduct, and spot D or protein adducts. was TG, which was confirmed by separate TLC application These preliminary data suggest that the formation of the of BPDE-I and TG. The radioactivities of the spots were as BPDE-I-TG adduct may be an important piece of evidence follows: A, 423232; B, 44862; C, 253215 and D, 151 c.p.m.
that lipids (especially esterified forms) can be directly damaged In a dose-response experiment, [1, H]BPDE-I-TG was by reactive carcinogens. The carcinogen-lipid adduct or lipid increasingly formed in vitro as a function of [1, H]BPDE-I damage may be useful biomarkers for carcinogen exposure, dose (Figure 3) . In a time-response experiment, the [1,3- although carcinogen-lipid adducts are limited to a TG adduct 3 H]BPDE-I-TG adduct reached a peak level 24 h after incubain this study. It is of interest whether the formation of a tion at 37°C and remained at this level for 48 h (data not carcinogen-lipid adduct plays a role in the process of chemical shown). The formation of the [1, H]BPDE-I-TG adduct was carcinogenesis. In the future, further investigation is needed further detected by HPLC analysis and chromatograms of the on the chemical structure of BPDE-I-TG, its biological role separations are shown in Figure 4 .
and any correlation with carcinogen-DNA or carcinogenIn animal experiments, a B[a]P-metabolite-lipid adduct protein adduct formation in human tissues. In addition, the was formed in the serum of rats orally treated with B[a]P development of better technology to detect TG adducts could (25 mg/rat). The fluorescent hue under UV light and the R f value of the B[a]P-metabolite-lipid adduct so formed, were facilitate their use for cancer research as well as risk assessment. 
